256 related articles for article (PubMed ID: 32749459)
1. Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trial.
Makkar RR; Kereiakes DJ; Aguirre F; Kowalchuk G; Chakravarty T; Malliaras K; Francis GS; Povsic TJ; Schatz R; Traverse JH; Pogoda JM; Smith RR; Marbán L; Ascheim DD; Ostovaneh MR; Lima JAC; DeMaria A; Marbán E; Henry TD
Eur Heart J; 2020 Sep; 41(36):3451-3458. PubMed ID: 32749459
[TBL] [Abstract][Full Text] [Related]
2. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial.
Makkar RR; Smith RR; Cheng K; Malliaras K; Thomson LE; Berman D; Czer LS; Marbán L; Mendizabal A; Johnston PV; Russell SD; Schuleri KH; Lardo AC; Gerstenblith G; Marbán E
Lancet; 2012 Mar; 379(9819):895-904. PubMed ID: 22336189
[TBL] [Abstract][Full Text] [Related]
3. Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction).
Malliaras K; Makkar RR; Smith RR; Cheng K; Wu E; Bonow RO; Marbán L; Mendizabal A; Cingolani E; Johnston PV; Gerstenblith G; Schuleri KH; Lardo AC; Marbán E
J Am Coll Cardiol; 2014 Jan; 63(2):110-22. PubMed ID: 24036024
[TBL] [Abstract][Full Text] [Related]
4. Effect of cardiosphere-derived cells on segmental myocardial function after myocardial infarction: ALLSTAR randomised clinical trial.
Ostovaneh MR; Makkar RR; Ambale-Venkatesh B; Ascheim D; Chakravarty T; Henry TD; Kowalchuk G; Aguirre FV; Kereiakes DJ; Povsic TJ; Schatz R; Traverse JH; Pogoda J; Smith RD; Marbán L; Marbán E; Lima JAC
Open Heart; 2021 Jul; 8(2):. PubMed ID: 34233913
[TBL] [Abstract][Full Text] [Related]
5. ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) Trial: Rationale and Design.
Chakravarty T; Makkar RR; Ascheim DD; Traverse JH; Schatz R; DeMaria A; Francis GS; Povsic TJ; Smith RR; Lima JA; Pogoda JM; Marbán L; Henry TD
Cell Transplant; 2017 Feb; 26(2):205-214. PubMed ID: 27543900
[TBL] [Abstract][Full Text] [Related]
6. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.
Traverse JH; Henry TD; Ellis SG; Pepine CJ; Willerson JT; Zhao DX; Forder JR; Byrne BJ; Hatzopoulos AK; Penn MS; Perin EC; Baran KW; Chambers J; Lambert C; Raveendran G; Simon DI; Vaughan DE; Simpson LM; Gee AP; Taylor DA; Cogle CR; Thomas JD; Silva GV; Jorgenson BC; Olson RE; Bowman S; Francescon J; Geither C; Handberg E; Smith DX; Baraniuk S; Piller LB; Loghin C; Aguilar D; Richman S; Zierold C; Bettencourt J; Sayre SL; Vojvodic RW; Skarlatos SI; Gordon DJ; Ebert RF; Kwak M; Moyé LA; Simari RD;
JAMA; 2011 Nov; 306(19):2110-9. PubMed ID: 22084195
[TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With ST-Segment Elevation Myocardial Infarction and Left Ventricular Dysfunction.
Fernández-Avilés F; Sanz-Ruiz R; Bogaert J; Casado Plasencia A; Gilaberte I; Belmans A; Fernández-Santos ME; Charron D; Mulet M; Yotti R; Palacios I; Luque M; Sádaba R; San Román JA; Larman M; Sánchez PL; Sanchís J; Jiménez MF; Claus P; Al-Daccak R; Lombardo E; Abad JL; DelaRosa O; Corcóstegui L; Bermejo J; Janssens S
Circ Res; 2018 Aug; 123(5):579-589. PubMed ID: 29921651
[TBL] [Abstract][Full Text] [Related]
8. The ALPHA phase 1 study: pulmonary ArteriaL hypertension treated with CardiosPHere-Derived allogeneic stem cells.
Lewis MI; Shapiro S; Oudiz RJ; Nakamura M; Geft D; Matusov Y; Hage A; Tapson VF; Henry TD; Azizad P; Saggar R; Mirocha J; Karpov OA; Van Eyk JE; Marbán E
EBioMedicine; 2024 Feb; 100():104900. PubMed ID: 38092579
[TBL] [Abstract][Full Text] [Related]
9. Durable Benefits of Cellular Postconditioning: Long-Term Effects of Allogeneic Cardiosphere-Derived Cells Infused After Reperfusion in Pigs with Acute Myocardial Infarction.
Kanazawa H; Tseliou E; Dawkins JF; De Couto G; Gallet R; Malliaras K; Yee K; Kreke M; Valle I; Smith RR; Middleton RC; Ho CS; Dharmakumar R; Li D; Makkar RR; Fukuda K; Marbán L; Marbán E
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26857066
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic cardiosphere-derived cells for the treatment of heart failure with reduced ejection fraction: the Dilated cardiomYopathy iNtervention with Allogeneic MyocardIally-regenerative Cells (DYNAMIC) trial.
Chakravarty T; Henry TD; Kittleson M; Lima J; Siegel RJ; Slipczuk L; Pogoda JM; Smith RR; Malliaras K; Marbán L; Ascheim DD; Marbán E; Makkar RR
EuroIntervention; 2020 Jul; 16(4):e293-e300. PubMed ID: 31763984
[TBL] [Abstract][Full Text] [Related]
11. Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial.
Chung ES; Miller L; Patel AN; Anderson RD; Mendelsohn FO; Traverse J; Silver KH; Shin J; Ewald G; Farr MJ; Anwaruddin S; Plat F; Fisher SJ; AuWerter AT; Pastore JM; Aras R; Penn MS
Eur Heart J; 2015 Sep; 36(33):2228-38. PubMed ID: 26056125
[TBL] [Abstract][Full Text] [Related]
12. Cardiosphere-Derived Cells Attenuate Inflammation, Preserve Systolic Function, and Prevent Adverse Remodeling in Rat Hearts With Experimental Autoimmune Myocarditis.
Nana-Leventaki E; Nana M; Poulianitis N; Sampaziotis D; Perrea D; Sanoudou D; Rontogianni D; Malliaras K
J Cardiovasc Pharmacol Ther; 2019 Jan; 24(1):70-77. PubMed ID: 30060693
[TBL] [Abstract][Full Text] [Related]
13. Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial.
Ishigami S; Ohtsuki S; Tarui S; Ousaka D; Eitoku T; Kondo M; Okuyama M; Kobayashi J; Baba K; Arai S; Kawabata T; Yoshizumi K; Tateishi A; Kuroko Y; Iwasaki T; Sato S; Kasahara S; Sano S; Oh H
Circ Res; 2015 Feb; 116(4):653-64. PubMed ID: 25403163
[TBL] [Abstract][Full Text] [Related]
14. Nonocclusive multivessel intracoronary infusion of allogeneic cardiosphere-derived cells early after reperfusion prevents remote zone myocyte loss and improves global left ventricular function in swine with myocardial infarction.
Suzuki G; Weil BR; Young RF; Fallavollita JA; Canty JM
Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H345-H356. PubMed ID: 31125261
[TBL] [Abstract][Full Text] [Related]
15. Validation of contrast-enhanced magnetic resonance imaging to monitor regenerative efficacy after cell therapy in a porcine model of convalescent myocardial infarction.
Malliaras K; Smith RR; Kanazawa H; Yee K; Seinfeld J; Tseliou E; Dawkins JF; Kreke M; Cheng K; Luthringer D; Ho CS; Blusztajn A; Valle I; Chowdhury S; Makkar RR; Dharmakumar R; Li D; Marbán L; Marbán E
Circulation; 2013 Dec; 128(25):2764-75. PubMed ID: 24061088
[TBL] [Abstract][Full Text] [Related]
16. Intracoronary infusion of Wharton's jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial.
Gao LR; Chen Y; Zhang NK; Yang XL; Liu HL; Wang ZG; Yan XY; Wang Y; Zhu ZM; Li TC; Wang LH; Chen HY; Chen YD; Huang CL; Qu P; Yao C; Wang B; Chen GH; Wang ZM; Xu ZY; Bai J; Lu D; Shen YH; Guo F; Liu MY; Yang Y; Ding YC; Yang Y; Tian HT; Ding QA; Li LN; Yang XC; Hu X
BMC Med; 2015 Jul; 13():162. PubMed ID: 26162993
[TBL] [Abstract][Full Text] [Related]
17. Widespread intracoronary allogeneic cardiosphere-derived cell therapy with and without cyclosporine in reperfused myocardial infarction.
Techiryan G; Weil BR; Young RF; Canty JM
Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H904-H916. PubMed ID: 36083793
[TBL] [Abstract][Full Text] [Related]
18. Effect of allogeneic adipose tissue-derived mesenchymal stromal cell treatment in chronic ischaemic heart failure with reduced ejection fraction - the SCIENCE trial.
Qayyum AA; van Klarenbosch B; Frljak S; Cerar A; Poglajen G; Traxler-Weidenauer D; Nadrowski P; Paitazoglou C; Vrtovec B; Bergmann MW; Chamuleau SAJ; Wojakowski W; Gyöngyösi M; Kraaijeveld A; Hansen KS; Vrangbaek K; Jørgensen E; Helqvist S; Joshi FR; Johansen EM; Follin B; Juhl M; Højgaard LD; Mathiasen AB; Ekblond A; Haack-Sørensen M; Kastrup J;
Eur J Heart Fail; 2023 Apr; 25(4):576-587. PubMed ID: 36644821
[TBL] [Abstract][Full Text] [Related]
19. Intracoronary Administration of Allogeneic Cardiosphere-Derived Cells Immediately Prior to Reperfusion in Pigs With Acute Myocardial Infarction Reduces Infarct Size and Attenuates Adverse Cardiac Remodeling.
Sousonis V; Sfakianaki T; Ntalianis A; Nanas I; Kontogiannis C; Aravantinos D; Kapelios C; Katsaros L; Nana M; Sampaziotis D; Sanoudou D; Papalois A; Malliaras K
J Cardiovasc Pharmacol Ther; 2021 Jan; 26(1):88-99. PubMed ID: 32677460
[TBL] [Abstract][Full Text] [Related]
20. Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial.
Assmus B; Walter DH; Seeger FH; Leistner DM; Steiner J; Ziegler I; Lutz A; Khaled W; Klotsche J; Tonn T; Dimmeler S; Zeiher AM
JAMA; 2013 Apr; 309(15):1622-31. PubMed ID: 23592107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
